SHARx Warns PBM Rebate Reform May Move Money Without Lowering Employer Costs

As regulators force greater transparency into pharmacy benefit management, SHARx says employers should look beyond rebate pass-through promises and determine whether total pharmacy costs are actually going down.

Pharmacy benefit manager (PBM) reform is accelerating, but employers expecting new rebate and transparency rules to automatically deliver lower prescription costs may need to take a wider view.

Paul Pruitt, Chief Growth Officer and Co-Founder of SHARx, a procurement management solution for high-cost prescription drugs, cautions that pressure on traditional PBM revenue streams may shift where revenue is captured without lowering employer drug costs.